Dr. Beth M. Silverstein, DO

Dr. Silverstein practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Silverstein's NPI, 1013104660, was assigned on September 27, 2007. Dr. Silverstein graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2007. Dr. Silverstein holds New York license 261123.

Dr. Silverstein's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Silverstein's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Silverstein is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Silverstein to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silverstein practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Silverstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Silverstein is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Silverstein is licensed in New York.

CMS data shows 84 Medicare services from Dr. Silverstein across 3 procedure codes in 2024, all of them office visits, for 78 Medicare patients. Medicare paid $12,127 for them. Every service was in an office.

CMS counts 78 Medicare patients who saw Dr. Silverstein in 2024. The largest group is 75 to 84, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Silverstein's median patient age at 48, with 62% women.

In 2024, Dr. Silverstein wrote 157 Medicare Part D claims for 67 patients. 94% of them were for generic drugs. CMS names the drug for 63 of them, across 4 drugs with 11 or more claims each, at $440 in total drug cost. In 2023, CMS named 191 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Silverstein for performance year 2024, reported as part of a group. Dr. Silverstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silverstein as offering telehealth.

CMS Open Payments shows 405 general payments to Dr. Silverstein from 47 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $2,003.

Dr. Silverstein graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2007. Dr. Silverstein is a member of AAN.